These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37762422)

  • 61. Spondyloepiphyseal dysplasias and bilateral legg-calvé-perthes disease: diagnostic considerations for mucopolysaccharidoses.
    Mendelsohn NJ; Wood T; Olson RA; Temme R; Hale S; Zhang H; Read L; White KK
    JIMD Rep; 2013; 11():125-32. PubMed ID: 23657977
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease.
    Caciotti A; Tonin R; Mort M; Cooper DN; Gasperini S; Rigoldi M; Parini R; Deodato F; Taurisano R; Sibilio M; Parenti G; Guerrini R; Morrone A
    BMC Med Genet; 2018 Oct; 19(1):183. PubMed ID: 30305043
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optimizing the molecular diagnosis of GALNS: novel methods to define and characterize Morquio-A syndrome-associated mutations.
    Caciotti A; Tonin R; Rigoldi M; Ferri L; Catarzi S; Cavicchi C; Procopio E; Donati MA; Ficcadenti A; Fiumara A; Barone R; Garavelli L; Rocco MD; Filocamo M; Antuzzi D; Scarpa M; Mooney SD; Li B; Skouma A; Bianca S; Concolino D; Casalone R; Monti E; Pantaleo M; Giglio S; Guerrini R; Parini R; Morrone A
    Hum Mutat; 2015 Mar; 36(3):357-68. PubMed ID: 25545067
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions?
    Tomatsu S; Montaño AM; Oikawa H; Dung VC; Hashimoto A; Oguma T; Gutiérrez ML; Takahashi T; Shimada T; Orii T; Sly WS
    Mol Genet Metab; 2015 Feb; 114(2):195-202. PubMed ID: 24953405
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mucopolysaccharidosis type IVA. N-acetylgalactosamine-6-sulfate sulfatase exonic point mutations in classical Morquio and mild cases.
    Fukuda S; Tomatsu S; Masue M; Sukegawa K; Iwata H; Ogawa T; Nakashima Y; Hori T; Yamagishi A; Hanyu Y
    J Clin Invest; 1992 Sep; 90(3):1049-53. PubMed ID: 1522213
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).
    Tomatsu S; Alméciga-Díaz CJ; Barbosa H; Montaño AM; Barrera LA; Shimada T; Yasuda E; Mackenzie WG; Mason RW; Suzuki Y; Orii KE; Orii T
    Expert Opin Orphan Drugs; 2013 Oct; 1(10):805-818. PubMed ID: 25419501
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular genetic assay of mucopolysaccharidosis IVA in South China.
    He D; Huang Y; Ou Z; Sheng H; Li S; Zhao X; Li R; Zheng J; Liu L
    Gene; 2013 Dec; 532(1):46-52. PubMed ID: 24035930
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mutations and polymorphisms in N-acetylgalactosamine-6-sulfate sulfatase gene in Turkish Morquio A patients.
    Khedhiri S; Chkioua L; Elcioglu N; Laradi S; Miled A
    Pathol Biol (Paris); 2014 Feb; 62(1):38-40. PubMed ID: 24411403
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA.
    Alméciga-Diaz CJ; Hidalgo OA; Olarte-Avellaneda S; Rodríguez-López A; Guzman E; Garzón R; Pimentel-Vera LN; Puentes-Tellez MA; Rojas-Rodriguez AF; Gorshkov K; Li R; Zheng W
    J Med Chem; 2019 Jul; 62(13):6175-6189. PubMed ID: 31188588
    [TBL] [Abstract][Full Text] [Related]  

  • 70. GALNS mutations in Indian patients with mucopolysaccharidosis IVA.
    Bidchol AM; Dalal A; Shah H; S S; Nampoothiri S; Kabra M; Gupta N; Danda S; Gowrishankar K; Phadke SR; Kapoor S; Kamate M; Verma IC; Puri RD; Sankar VH; Devi AR; Patil SJ; Ranganath P; Jain SJ; Agarwal M; Singh A; Mishra P; Tamhankar PM; Gopinath PM; Nagarajaram HA; Satyamoorthy K; Girisha KM
    Am J Med Genet A; 2014 Nov; 164A(11):2793-801. PubMed ID: 25252036
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inflammatory process and oxidative/nitrative stress: in vivo study in mucopolysaccharidosis type IV A patients under long-term enzyme replacement therapy.
    Aguilar Delgado C; Hammerschmidt T; Faverzini JL; Lopes F; Giugliani R; Baldo G; Vargas CR
    Arch Biochem Biophys; 2023 Mar; 737():109541. PubMed ID: 36754222
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnosis of Morquio Syndrome in Dried Blood Spots Based on a New MRM-MS Assay.
    Cozma C; Eichler S; Wittmann G; Flores Bonet A; Kramp GJ; Giese AK; Rolfs A
    PLoS One; 2015; 10(7):e0131228. PubMed ID: 26147980
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.
    Sawamoto K; Tomatsu S
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450640
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnosing Mucopolysaccharidosis type IV a by the fluorometric assay of N-Acetylgalactosamine-6-sulfate sulfatase activity.
    Shams S; Barazandeh Tehrani M; Civallero G; Minookherad K; Giugliani R; Setoodeh A; Haghi Ashtiani MT
    J Diabetes Metab Disord; 2017; 16():37. PubMed ID: 28904929
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The GALNS p.P77R variant is a probable Gujarati-Indian founder mutation causing Mucopolysaccharidosis IVA syndrome.
    Sheth H; Naik P; Shah M; Bhavsar R; Nair A; Sheth F; Sheth J
    BMC Genomics; 2022 Jun; 23(1):458. PubMed ID: 35729508
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Practical and reliable enzyme test for the detection of mucopolysaccharidosis IVA (Morquio Syndrome type A) in dried blood samples.
    Camelier MV; Burin MG; De Mari J; Vieira TA; Marasca G; Giugliani R
    Clin Chim Acta; 2011 Sep; 412(19-20):1805-8. PubMed ID: 21684269
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns.
    Chien YH; Lee NC; Chen PW; Yeh HY; Gelb MH; Chiu PC; Chu SY; Lee CH; Lee AR; Hwu WL
    Orphanet J Rare Dis; 2020 Feb; 15(1):38. PubMed ID: 32014045
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based nanoparticles.
    Leal AF; Cifuentes J; Torres CE; Suárez D; Quezada V; Gómez SC; Cruz JC; Reyes LH; Espejo-Mojica AJ; Alméciga-Díaz CJ
    Sci Rep; 2022 Sep; 12(1):15045. PubMed ID: 36057729
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enzyme replacement therapy in a murine model of Morquio A syndrome.
    Tomatsu S; Montaño AM; Ohashi A; Gutierrez MA; Oikawa H; Oguma T; Dung VC; Nishioka T; Orii T; Sly WS
    Hum Mol Genet; 2008 Mar; 17(6):815-24. PubMed ID: 18056156
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Five novel mutations of GALNS in Korean patients with mucopolysaccharidosis IVA.
    Park HD; Ko AR; Ki CS; Lee SY; Kim JW; Cho SY; Kim SH; Park SW; Sohn YB; Jin DK
    Am J Med Genet A; 2013 Mar; 161A(3):509-17. PubMed ID: 23401410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.